Masimo (NASDAQ:MASI) Cut to Equal Weight at Wells Fargo & Company

Wells Fargo & Company downgraded shares of Masimo (NASDAQ:MASI) from an overweight rating to an equal weight rating in a report issued on Wednesday, Marketbeat reports. The firm currently has $180.00 price target on the medical equipment provider’s stock, down from their prior price target of $190.00.

A number of other research analysts have also recently commented on the company. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday. Stifel Nicolaus set a $180.00 price target on Masimo in a report on Tuesday. Bank of America assumed coverage on shares of Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective on the stock. Finally, Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Monday, December 1st. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Masimo currently has an average rating of “Hold” and a consensus price target of $181.17.

Masimo Stock Down 0.1%

Shares of NASDAQ:MASI opened at $175.10 on Wednesday. The stock has a 50-day simple moving average of $139.13 and a 200-day simple moving average of $143.16. The stock has a market capitalization of $9.40 billion, a P/E ratio of -16.61, a PEG ratio of 1.78 and a beta of 1.26. Masimo has a 1 year low of $125.94 and a 1 year high of $194.88. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. MAI Capital Management grew its holdings in shares of Masimo by 176.7% during the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares during the last quarter. Global Retirement Partners LLC bought a new position in Masimo during the 4th quarter worth $27,000. Aster Capital Management DIFC Ltd acquired a new stake in Masimo in the fourth quarter worth $28,000. Los Angeles Capital Management LLC acquired a new stake in Masimo in the fourth quarter worth $31,000. Finally, Rothschild Investment LLC lifted its stake in Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares during the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.